Guardian Pharmacy Services (NYSE:GRDN) Trading 4.6% Higher – Still a Buy?

Guardian Pharmacy Services, Inc. (NYSE:GRDN)’s share price was up 4.6% during mid-day trading on Monday . The company traded as high as $22.43 and last traded at $22.39. Approximately 37,424 shares changed hands during trading, a decline of 80% from the average daily volume of 188,664 shares. The stock had previously closed at $21.41.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on GRDN. Raymond James assumed coverage on Guardian Pharmacy Services in a research report on Monday, October 21st. They issued an “outperform” rating and a $21.00 price target on the stock. Stephens began coverage on Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 target price for the company. Finally, Truist Financial increased their price target on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a research report on Friday, November 15th.

Guardian Pharmacy Services Trading Up 8.7 %

The company’s 50-day simple moving average is $21.19.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The firm had revenue of $314.39 million during the quarter, compared to the consensus estimate of $303.21 million. Equities analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Steven D. Cosler bought 7,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 19th. The shares were acquired at an average price of $21.22 per share, with a total value of $148,540.00. Following the transaction, the director now owns 17,713 shares in the company, valued at $375,869.86. This represents a 65.34 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Thomas J. Salentine, Jr. purchased 35,714 shares of Guardian Pharmacy Services stock in a transaction on Friday, September 27th. The shares were purchased at an average cost of $14.00 per share, with a total value of $499,996.00. Following the transaction, the director now owns 35,714 shares in the company, valued at approximately $499,996. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here.

Institutional Investors Weigh In On Guardian Pharmacy Services

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Franklin Resources Inc. bought a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at about $8,575,000. Wellington Management Group LLP acquired a new position in shares of Guardian Pharmacy Services during the 3rd quarter worth approximately $8,400,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Guardian Pharmacy Services during the 3rd quarter worth approximately $5,460,000. Maven Securities LTD bought a new stake in shares of Guardian Pharmacy Services during the 3rd quarter worth approximately $3,033,000. Finally, Seven Grand Managers LLC acquired a new stake in shares of Guardian Pharmacy Services in the 3rd quarter valued at approximately $2,515,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.